NL-OMON26111招募中不适用
Efficacy and feasibility of first-line treatment with risk-adapted dose-adjusted EPOCH-R (DA-EPOCH-R) in patients with Burkitt lymphoma. A phase II clinical trial.
VU University Medical Center Amsterdam0 个研究点目标入组 22 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 22
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. First diagnosis of Burkitt lymphoma, histological confirmed according to the WHO classification 2008;
- •2. Age ≥ 18 years;
排除标准
- •1. All histopathological diagnoses other than BL according to the WHO classification 2008, irrespective of the presence of MYC rearrangement;
- •2. Inadequate renal function or creatinine clearance < 50 ml/min unless lymphoma related;
研究者
相似试验
尚未招募
不适用
Efficacy and safety of first-line therapy with chlorambucil, rituximab and lenalidomide (Revlimid®) (CR2) in elderly patients and young frail patients with advanced Chronic Lymphocytic Leukemia (CLL): A phase II trial.Advanced previously untreated Chronic Lymphocytic LeukemiaNL-OMON23278Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON) P/a HOVON Data CenterErasmus MC - Daniel den HoedP.O. box 52013008 AE RotterdamTel: +31 10 7041560Fax: +31 10 7041028e-mail: hdc@erasmusmc.nl62
已完成
2 期
Efficacy and feasibility of first-line treatment with risk-adapted dose-adjusted EPOCH-R (DA-EPOCH-R) in patients with Burkitt lymphoma. A phase II clinical trial.Burkitt lymphomahighly aggressive B cell lymphoma10025320NL-OMON36941Vrije Universiteit Medisch Centrum22
进行中（未招募）
不适用
A trial to investigate treatment with EPOCH-R in patients with Burkitt lymphoma, by adapting the dose to the risk classification of the disease.Burkitt lymphomaMedDRA version: 14.1Level: HLTClassification code 10006596Term: Burkitt's lymphomasSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2012-003141-16-NLVU University Medical Center
尚未招募
2 期
First-Line Treatment Induced With mFOLFOX6 and HLX04 Regimen, Following Combined With Serplulimab in MSS Initially Unresectable Metastatic Colorectal CancerEfficacy, SelfSafety IssuesColo-rectal CancerNCT06491355Sir Run Run Shaw Hospital72
Unknown
不适用
Bronchoscopic Microwave Intervention Treatment in Advanced Central NSCLCEffect IncreasedSafety IssuesNCT04360655Shanghai Pulmonary Hospital, Shanghai, China50